{
    "nctId": "NCT02981485",
    "briefTitle": "Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China",
    "officialTitle": "Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Change in arm volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\nBreast cancer diagnosis regardless of the date of operation and identified unilateral arm lymphedema Stage \u2161 of lymphedema according to the standard of International Society of Lymphology The patient is able to read, understand, and complete questionnaires. Completed radiotherapy and/or chemotherapy at least 2 months prior to inclusion The patient understands the nature and purpose of this study and the study procedures and has signed informed consent.\n\nExclusion Criteria:\n\nRelapse of breast cancer Untreated infection Untreated heart failure Untreated renal failure Untreated deep venous thrombosis in the arm Iodine allergy Pregnancy Psychiatric disorders",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT"
}